đđŤđđđ đđđŤđŹđŽđŹ đđ¨đŹđ đđ˘đŹđđđŹđ đđŤđđđđŚđđ§đ đđđŤđ¤đđ đđ˘đłđ đđ˛ 2024-2032
The global graft versus host disease treatment market was valued at US$ 2,567.6 million in 2023 and is expected to register a CAGR of 8.4% over the forecast period and reach US$ 5,306.1 million in 2032.
đđđđ đŚđ¨đŤđ: https://www.reportsandinsights.....com/report/graft-ve
×××
ת××××
×Öˇ×Ö˛××֚ק
